Page last updated: 2024-10-31

nefazodone and Cirrhosis, Liver

nefazodone has been researched along with Cirrhosis, Liver in 2 studies

nefazodone: may be useful as an opiate adjunct

Research Excerpts

ExcerptRelevanceReference
" Subjects with liver cirrhosis had about a two-fold greater systemic exposure to nefazodone and hydroxynefazodone compared with normal subjects after a single dose of nefazodone, the difference decreasing to approximately 25% at steady state."3.69Single- and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosis. ( Barbhaiya, RH; Behr, DA; Greene, DS; Natarajan, CS; Sainati, SM; Shukla, UA, 1995)
" Serial blood samples for pharmacokinetic analysis were collected for 48 h following each dose and plasma samples were assayed for NEF, HO-NEF and mCPP by a validated HPLC method."1.29Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment. ( Barbhaiya, RH; Greene, DS; Shukla, UA, 1995)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbhaiya, RH2
Shukla, UA2
Natarajan, CS1
Behr, DA1
Greene, DS2
Sainati, SM1

Other Studies

2 other studies available for nefazodone and Cirrhosis, Liver

ArticleYear
Single- and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosis.
    Clinical pharmacology and therapeutics, 1995, Volume: 58, Issue:4

    Topics: Adult; Antidepressive Agents; Dose-Response Relationship, Drug; Female; Humans; Liver Cirrhosis; Mal

1995
Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment.
    European journal of clinical pharmacology, 1995, Volume: 49, Issue:3

    Topics: Administration, Oral; Adult; Age Factors; Aged; Antidepressive Agents; Female; Humans; Kidney Diseas

1995